These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 13830778)

  • 1. [Pharmacodynamic effect of degranol].
    HADNAGY C; GUNDISCH M; GYERGYAY F; KREPSZ I; EPERJESSY A; KISS A; MALATINSZKY GE; KEMENY G; FESZT T; CSGEDI J
    Arch Int Pharmacodyn Ther; 1959 Jul; 120():334-42. PubMed ID: 13830778
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of nitrogen mustard and degranol on the activity of acid and alkaline phosphatases of rat and guinea pig organs].
    KEMENY G; GUENDISCH M; FESZT T; HADNAGY C
    Acta Histochem; 1960 Apr; 9():1-6. PubMed ID: 14405340
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogeneity of tumour ribonucleic acid and the effect of 'degranol' on it.
    ANTONI F; HIDVEGI EJ; LAPIS K
    Nature; 1960 Apr; 186():81-2. PubMed ID: 13793874
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative studies on the effect of dimethanesulfonyl-D-mannitol and mannitol mustard on animal leukemia].
    NEMETH L; GAL F
    Arzneimittelforschung; 1962 Feb; 12():197-8. PubMed ID: 14478984
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experience with degranol].
    CSOMOR G
    Lijec Vjesn; 1961 Oct; 83():1043-51. PubMed ID: 13882540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on the mechanism of action of degranol (BCM)].
    KONSANSZKY A
    Pathol Microbiol (Basel); 1960; 23():788-97. PubMed ID: 13752996
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of the effect of degranol.
    SANDOR L; CERNY V; UJHAZY V; WINKLER A
    Neoplasma; 1959; 6():179-82. PubMed ID: 14441442
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of chemotherapeutics on the nucleic acid metabolism of tumours. Incorporation of 32P into nucleic acids following treatment with degranol.
    HIDVEGI EJ; ANTONI F; LAPIS K
    Br J Cancer; 1960 Mar; 14(1):139-46. PubMed ID: 14401715
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in the lipid composition of tumour and hepatic tissues of rats bearing Guerin carcinoma following treatment with the nitrogen mustard degranol.
    HAGONY PL; JAKY M
    Biochem Pharmacol; 1960 Oct; 5():46-52. PubMed ID: 13903655
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas.
    LASZLO J; GRIZZLE J; JONSSON U; RUNDLES RW
    Cancer Chemother Rep; 1962 Feb; 16():247-50. PubMed ID: 14462650
    [No Abstract]   [Full Text] [Related]  

  • 11. [The action of vaccinia and herpes viruses and of the cytostatic drugs, degranol and TEM, on several experimental pulmonary tumors].
    COSTACHEL O; ILIE B
    Stud Cercet Inframicrobiol; 1961; 12():317-23. PubMed ID: 13881598
    [No Abstract]   [Full Text] [Related]  

  • 12. Mannomustine in treatment of leukaemias, polycythaemia, and malignant disorders.
    BARLOW AM; LEEMING JT; WILKINSON JF
    Br Med J; 1959 Aug; 2(5146):208-13. PubMed ID: 13671231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Degranol and other chemotherapeutic agents].
    SAVNIK L
    Magy Onkol; 1962 Mar; 6():9-14. PubMed ID: 14497637
    [No Abstract]   [Full Text] [Related]  

  • 14. [5-year clinical experience with Degranol].
    SELLEI C; ECKHARDT S
    Orv Hetil; 1962 Jun; 103():1168-72. PubMed ID: 13910449
    [No Abstract]   [Full Text] [Related]  

  • 15. On the treatment of granuloma fungoides with degranol.
    VENKEI T; BAKOS L
    Acta Unio Int Contra Cancrum; 1960; 16():929-31. PubMed ID: 13841675
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    RAEVSKII IG
    Vopr Onkol; 1962; 8(4)():3-11. PubMed ID: 14489811
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of 1,6-bis(2-bromoethylamino)-1,6-didesoxy-D-mannitol dihydrobromide on transplanted animal cancer].
    VIALLIER J; PELLET H
    C R Seances Soc Biol Fil; 1960; 154():362-5. PubMed ID: 13842055
    [No Abstract]   [Full Text] [Related]  

  • 18. NITROGEN MUSTARD-RESISTANT YOSHIDA SARCOMA AND CROSS-RESISTANCE STUDIES.
    UJHAZY V; WINKLER A
    Neoplasma; 1965; 12():11-4. PubMed ID: 14278323
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimenttal studies on the tumor growth-inhibiting effect of DBM (R13) (1,6-bis(2-bromoethylamino)-1,6-desoxy-D-mannitol dihydrobromide)].
    BALO J; KENDREY G; JUHASZ J; BESZNYAK I
    Orv Hetil; 1960 Jan; 101():157-61. PubMed ID: 13796294
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on the inhibiting effect of a new nitrogen mustard derivative, 1, 6-bis(beta-chloraethylamino)-1, 6-desoxy-D-mannitol dihydrochloride (BCM), on tumor growth].
    KELLNER B; NEMETH L
    Orv Hetil; 1956 Sep; 97(36):981-4. PubMed ID: 13388307
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.